SCHEMBL24466772

SCHEMBL24466772

c1ccc2c(c1)Oc1ccccc1C21c2ccccc2-c2cc(-c3ccc(-c4cc(-c5nc6ccccc6s5)cc(-c5nc6ccccc6s5)c4)cc3)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
RAB9A P51151 7/20 0.43
KDM4E B2RXH2 6/20 0.43
NPC1 O15118 5/20 0.43
ALDH1A1 P00352 4/20 0.43
MAPT P10636 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
NFKB1 P19838 3/20 0.43
NFKB2 Q00653 3/20 0.43
RELA Q04206 3/20 0.43
LMNA P02545 3/20 0.43
HPGD P15428 2/20 0.43
TP53 P04637 2/20 0.43
PKM P14618 2/20 0.43
HSD17B10 Q99714 2/20 0.43
TDP2 O95551 1/20 0.43
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24466694 0.99 APP (0.44) APPMMP9MMP8RAB9AKDM4E
SCHEMBL24476883 0.97 RAB9A (0.45) APPMMP9MMP8RAB9AKDM4E
SCHEMBL24476882 0.97 RAB9A (0.45) APPMMP9MMP8RAB9AKDM4E
SCHEMBL24476881 0.97 RAB9A (0.45) APPMMP9MMP8RAB9AKDM4E
SCHEMBL24466696 0.96 APP (0.41) APPMMP9MMP8RAB9AKDM4E
SCHEMBL24476673 0.94 TDP2 (0.46) APPMMP9MMP8RAB9AKDM4E
SCHEMBL24466710 0.94 RAB9A (0.46) APPMMP9MMP8RAB9AKDM4E
SCHEMBL24476775 0.94 APP (0.40) APPMMP9MMP8RAB9AKDM4E
SCHEMBL24466794 0.93 KDM4E (0.44) APPMMP9MMP8RAB9AKDM4E
SCHEMBL24476777 0.93 TDP2 (0.39) APPMMP9MMP8RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220173333-A1 HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF CHANGCHUN HYPERIONS TECHNOLOGY CO., LTD (CN) 2022-06-02 US disclosed
EP-4006025-A1 HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF Changchun Hyperions Technology Co., Ltd. (CN) 2022-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220173333-A1 HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF KCNH1, OCIAD2, ETFB APP 1335/4885MMP9 2263/4885MMP8 4713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.